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Routine prenatal human immunodeficiency virus (HIV) 
screening provides a critical opportunity to diagnose HIV 
infection, begin chronic care, and prevent mother-to-child 
transmission. However, little is known about the preva-
lence  of  prenatal  HIV  testing  in  the  US-Mexico  border 
region. We explored the correlation between prenatal HIV 
testing and sociodemographic, health behavior, and health 
exposure characteristics.
Methods
The  study  sample  consisted  of  women  who  delivered 
live infants in 2005 in hospitals with more than 100 deliv-
eries  per  year  and  resided  in  Matamoros,  Tamaulipas, 
Mexico (n = 489), or Cameron County, Texas (n = 458). We 
examined univariate and bivariate distributions of HIV 
testing in Matamoros and Cameron County and quanti-
fied the difference in odds of HIV testing by using logistic 
regression.
Results
The prevalence of prenatal HIV testing varied by place 
of residence — 57.6% in Matamoros and 94.8% in Cameron 
County.  Women  in  Cameron  County  were  significantly 
more likely than those in Matamoros to be tested. Marital 
status, education, knowledge of methods to prevent HIV 
transmission (adult-to-adult), discussion of HIV screening 
with a health care professional during prenatal care, and 
previous  HIV  testing  were  significantly  associated  with 
prenatal HIV testing in Matamoros, although only the lat-
ter 2 variables were significant in Cameron County.
Conclusion
Although national policies in both the United States and 
Mexico  recommend  prenatal  testing  for  HIV,  a  greater 
proportion  of  women  in  Cameron  County  were  tested, 
compared  with  women  in  Matamoros.  Efforts  between 
Matamoros and Cameron County to improve HIV testing 
during pregnancy in the border region should consider cor-
relates for testing in each community.
Introduction
Human  immunodeficiency  virus  (HIV)/AIDS  was  first 
thought to be an acute disease (1,2); however, recent devel-
opments in treatment have transformed HIV/AIDS into a 
chronic condition. The projected life expectancy for those 
infected with HIV, if they remain in optimal HIV care, 
has increased from less than 7 years in 1993 to more than 
20 years today (1), but optimal care cannot begin without 
a diagnosis. Routinely testing women prenatally for HIV 
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provides a unique and critical opportunity to diagnose HIV 
infection, begin chronic care, and prevent mother-to-child 
transmission.
Perinatal  transmission  can  be  prevented  in  several 
ways: using antiretroviral drugs for treatment and pro-
phylaxis,  avoiding  breastfeeding,  and  electing  to  have 
cesarean delivery when appropriate (3-5). Through 2005, 
91%  of  AIDS  cases  reported  among  children  aged  12 
years and younger in the United States were attributed 
to perinatal transmission (3,4). The number of estimated 
perinatal HIV infections peaked in 1991 at 1,650 cases and 
then declined sharply to approximately 142 cases in 2005 
(3,6,7). The rate of perinatal transmission is less than 2% 
with intervention (3,8), compared with 25% to 30% with-
out intervention (3,9).
If a woman is not tested for HIV during her pregnancy, 
an  opportunity  for  intervention  is  lost  (10).  Estimates 
from the 2004 Pregnancy Risk Assessment Monitoring 
System (PRAMS) suggest that 87% of women in Texas 
were tested for HIV during their most recent pregnancy. 
This figure is higher than the national US estimate of 
69%  reported  in  the  2002  National  Survey  of  Family 
Growth  (11).  Currently,  no  estimates  are  available  for 
prenatal HIV testing in the state of Tamaulipas or for 
Mexico overall. Very little is known about the prevalence 
of prenatal HIV testing on the Texas-Tamaulipas border; 
however,  2.4%  of  AIDS  cases  in  Mexico  are  pediatric 
cases,  most  of  which  resulted  from  transmission  from 
mother  to  child  (12).  In  2000,  the  Mexican  National 
Center for AIDS Prevention (CENSIDA) released an esti-
mate of 0.04% HIV prevalence among pregnant women 
for  1991  through  1995  (10).  A  2003  survey  of  women 
tested perinatally in Tijuana found a higher HIV preva-
lence of 0.65% (12).
Officials from both states, Texas and Tamaulipas, con-
sider the border area to be unique and culturally distinct 
from the rest of the state or country (13). Border residents 
share the same cultural identity and are exposed to the 
same economic conditions, including severe poverty and 
lack of services (14). The United States and Mexico have 
engaged in binational collaborations to address the unique 
public health needs of the border population, including the 
United States–Mexico Border Health Association and the 
United States-Mexico Border Health Commission (15,16). 
The  prevalence  of  prenatal  HIV  testing  in  Texas  and 
Tamaulipas does not provide information about prenatal 
HIV testing on the border. Consequently, the objectives 
of this study were to 1) report the prevalence of prenatal 
HIV testing among women who lived in Cameron County, 
Texas,  and  among  women  who  lived  in  Matamoros, 
Tamaulipas,  Mexico,  and  2)  examine  the  association 
between  prenatal  HIV  testing  and  sociodemographic   
factors,  health  behaviors,  and  health  exposures  for  the 
sample as a whole as well as for women in each border 
community. These analyses focused primarily on individu-
al-level characteristics. Other correlates for prenatal HIV 
testing include national policy and local practice, which 
were not directly measured.
Methods
We used primary data collected from 2002 through 2006 
from the Brownsville-Matamoros Sister City Project for 
Women’s Health (BMSCP). Brownsville is in the Texas 
Rio  Grande  Valley,  and  Matamoros  is  a  municipality 
in the state of Tamaulipas, Mexico (Figure). Data from 
Brownsville  were  actually  collected  in  all  of  Cameron 
County,  which  is  on  the  southern  tip  of  Texas,  adja-
cent to Tamaulipas. The city centers of Brownsville and 
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Figure. Map of the US-Mexico Border Region and Cameron County, Texas, 
and Matamoros, Tamaulipas, Mexico (Red Box). (The authors thank Allison 
Abell Banicki of the Office of Border Health, Texas Department of State 
Health Services, for creating this map.)Matamoros  are  only  approximately  2  km  apart,  and 
one can easily travel between them by crossing any of 3   
bridges that connect the cities.
The  survey  design  team  selected  the  sample  for  the 
study  from  among  women  who  delivered  live  infants 
on  selected  days  between  August  21  and  November  9, 
2005; participants lived in either Matamoros or Cameron 
County.  Interviewers  conducted  computer-assisted  per-
sonal  interviews.  The  Centers  for  Disease  Control  and 
Prevention  reviewed  this  surveillance  pilot  project  for 
human subjects concerns and determined it to be “nonre-
search” or public health practice. Therefore, institutional 
review board approval was not required.
The  sampling  design  consisted  of  stratified  cluster 
sampling, and clusters were systematically selected. The 
survey  design  team  selected  all  hospitals  in  each  area 
(Matamoros and Cameron County) that reported 100 or 
more deliveries per year. Within each hospital stratum, 
clusters  of  2-day  blocks  were  selected.  All  women  who 
gave birth to a live infant on a selected day, regardless of 
the time of day, were included in the sample. Interviewers 
identified  eligible  participants  by  periodically  reviewing 
hospital  delivery  logs  and  medical  records  and  contact-
ing  hospital  staff.  For  a  more  thorough  description  of 
data collection, please see McDonald et al in this issue of 
Preventing Chronic Disease (17).
The survey design team created weights to account for 
probability of selection, population noncoverage, hospital 
noncoverage, and nonresponse. We used SUDAAN version 
9.03 (RTI International, Research Triangle Park, North 
Carolina) to account for the complex survey design, which 
was necessary to allow for appropriate specification of the 
sampling design parameters.
We  used  univariate  and  bivariate  distributions  for 
women from Cameron County, women from Matamoros, 
and  the  total  sample  to  measure  prevalence  of  HIV 
testing during pregnancy. The outcome of interest was 
measured with the question, “At any time during your 
most recent pregnancy or during delivery, did you have 
a test for HIV, the virus that causes AIDS?” Correlates 
of HIV testing were identified by using logistic regres-
sion  for  women  from  Cameron  County,  women  from 
Matamoros, and the total sample. In the regressions, the 
outcome variable was prenatal HIV testing. We selected 
candidates  for  the  regressions  from  variables  included 
in  the  bivariate  analyses.  Each  variable  was  included 
in a bivariate logistic regression with the outcome vari-
able. We included only those variables that generated P 
values ≤ .10 in at least 1 place of residence (Matamoros 
or  Cameron  County)  in  the  multivariate  regressions. 
Interaction terms were included in a multivariate model 
for the total sample to confirm the role of place of resi-
dence. Variables were not retained in the model if they 
were not significant at α = .05. Thus, models presented 
here are parsimonious. The first iteration of regression 
models included the item, “Were you offered an HIV test 
during  your  most  recent  pregnancy  or  delivery?”  This 
variable was removed, however, because it was highly 
correlated with the outcome variable.
Most of the items collected for these analyses were self-
reported. The survey design team measured most of the 
items about HIV, including the outcome measure, by using 
questions from PRAMS. This team took the item measuring 
knowledge of HIV infection prevention from Demographic 
and  Health  Surveys  (DHS)  (18)  and  the  Joint  United 
Nationals Programme on HIV/AIDS (UNAIDS). The team 
operationalized  knowledge  of  HIV  infection  prevention 
in  accordance  with  the  Compendium  of  Indicators  for 
Evaluating  Reproductive  Health  Programs  (http://www.
cpc.unc.edu/measure/publications/html/ms-02-06.html). 
Respondents had knowledge of HIV infection prevention if 
they reported they could reduce the risk of adult-to-adult 
transmission by using condoms or having sex only with a 
single, uninfected partner. The team modified the mea-
sure of HIV risk from UNAIDS and DHS. Interviewers 
read the following item, “I am going to read a list of 3 
activities. When I’m done, please tell me if any of the situ-
ations apply to you. You do not need to tell me which one. 
You have used intravenous drugs in the past year; you 
have been treated for a sexually transmitted disease, sexu-
ally transmitted infection, or venereal disease in the past 
year; you have had multiple (more than 2) sex partners in 
the past year.” The response categories were yes (1 or more 
applies) or no (none apply).
Although interviewers collected data at hospitals where 
women  delivered,  this  project  used  place  of  residence 
as the key location variable. Programs and policies in a 
woman’s place of residence are likely to affect her health 
and pregnancy more than those in the place of delivery, 
particularly for the outcome of interest, HIV testing dur-
ing pregnancy or delivery.
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Results
Women in each community were similar in age, employ-
ment,  and  health  coverage  during  pregnancy  (Table  1). 
They  varied  in  terms  of  education,  marital  status,  and 
health coverage before pregnancy. A greater proportion of 
women in Cameron County had a high school diploma or 
more. A greater proportion of women in Matamoros were 
either  cohabitating  or  married.  A  larger  percentage  of 
women in Cameron County were without health coverage 
before pregnancy.
The prevalence of prenatal HIV testing in Matamoros 
was approximately 37 percentage points lower than the 
prevalence  of  HIV  testing  in  Cameron  County  in  2005 
(Table 2). Other notable differences included timing of pre-
natal care, being offered an HIV test, HIV testing before 
pregnancy,  knowledge  of  HIV  infection  prevention,  and 
risk behaviors among women in the sample. A greater pro-
portion of women in Cameron County than in Matamoros 
entered  prenatal  care  during  their  first  trimester.  A 
larger proportion of women in Cameron County than in 
Matamoros were offered an HIV test. Although a higher 
percentage of women in Cameron County were tested for 
HIV before the reference pregnancy, a higher percentage 
of  women  in  Matamoros  were  tested  within  6  months 
before their pregnancy. A greater proportion of women in 
Cameron County reported 1 of 2 effective methods to pre-
vent HIV transmission, but a larger proportion of women 
in Matamoros mentioned both condom use and monogamy 
to prevent transmission.
A  greater  proportion  of  women  in  Cameron  County 
than in Matamoros engaged in behaviors associated with 
increased risk of HIV before pregnancy. The prevalence 
of smoking in Cameron County was more than 1.5 times 
that in Matamoros. The prevalence of drinking and binge 
drinking in Cameron County was more than twice that in 
Matamoros.  In  contrast,  the  prevalences  of  intravenous 
drug use, treatment for a sexually transmitted disease, 
or multiple partners in the past year were identical for 
both communities. Smoking and drinking were included 
in initial regressions but were not significantly associated 
with HIV testing because they did not vary substantially 
among women who were tested for HIV.
The bivariate results are category-specific (Table 3 and 
Table 4). For example, the first row under “age” in Table 3 
should be read as “48.6% of the women aged 14 to 19 who 
lived in Mexico were tested for HIV.” The bivariate results 
show that a greater proportion of women across all cat-
egories were tested during pregnancy in Cameron County 
than  in  Matamoros.  Indeed,  there  was  little  variation 
across categories within Cameron County because of the 
high testing rate. In terms of demographics, a smaller pro-
portion of cohabitating women in Matamoros were tested 
for HIV compared with single and married women. Also, a 
smaller proportion of women in Matamoros with 7 years of 
education or less were tested compared with women with 
8 or more years of education.
In terms of exposure to HIV education, testing, and risk 
behaviors, the differences between women in Matamoros 
and those in Cameron County reflected the high prenatal 
testing  rate  in  Cameron  County.  Women  in  Cameron 
County  were  consistently  tested  at  higher  rates  in  all 
categories. Notable differences in Matamoros were seen 
in the categories for prenatal care, knowledge of effective 
HIV infection prevention, and exposure to risk. A smaller 
proportion of women who did not receive prenatal care as 
early as they wanted were tested for HIV, compared with 
women  who  received  prenatal  care  when  they  wanted. 
A smaller proportion of women who mentioned condom 
use  were  tested  compared  with  women  who  mentioned 
monogamy or both condom use and monogamy as an effec-
tive prevention method. Finally, only two-thirds of women 
who engaged in HIV risk behaviors in the previous year 
were tested during the reference pregnancy.
Of  those  not  tested  for  HIV  during  their  pregnancy, 
91.0% (95% confidence interval [CI], 86.7%-93.4%) lived 
in  Matamoros.  Of  the  women  who  lived  in  Matamoros 
who  were  not  tested  for  HIV  before  their  pregnancy, 
51.3% (95% CI, 46.6%-56.0%) were not tested during the 
reference pregnancy (compared with 9.6% [95% CI, 6.2%-
14.6%] in Cameron County).
The  results  of  logistic  regression  demonstrated  that 
for the total sample, place of residence, older age, testing 
before  pregnancy,  discussion  of  testing  during  prenatal 
care, and knowledge of HIV infection prevention methods 
were  significantly  associated  with  prenatal  HIV  testing 
(Table 5). Women who resided in Cameron County were 
significantly more likely to be tested for HIV prenatally 
than  were  women  who  resided  in  Matamoros.  Women 
aged 35 to 43 years had nearly 3 times the odds for test-
ing as women in the youngest age group (14 to 19 years). 
Women who had been tested for HIV before the reference 
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ing the reference pregnancy. Women who discussed HIV 
testing  during  prenatal  care  with  a  health  care  profes-
sional were significantly more likely to be tested than were 
women who did not. Finally, mentioning either or both 
effective  HIV  infection  prevention  methods  was  signifi-
cantly associated with having been tested for HIV. These 
results  are  parsimonious;  nonsignificant  variables  were 
not kept in the final model.
Three of the variables presented in Table 5 were also sig-
nificant in the Matamoros-specific regression and behaved 
similarly (testing before pregnancy, discussion of testing 
during  prenatal  care,  and  knowledge  of  effective  infec-
tion prevention) (Table 6). In addition, marital status and 
education were associated with HIV testing among women 
who resided in Matamoros. Cohabitation was associated 
with a lower likelihood of having been tested than was 
being married. Women with a high school diploma were 
also more likely to have been tested than were women who 
had less than a seventh-grade education.
The high prevalence of prenatal HIV testing in Cameron 
County  left  little  room  for  variation  in  the  community- 
specific  regression.  Only  2  variables  were  significantly 
associated with having been tested: having had an HIV 
test before the reference pregnancy (odds ratio [OR], 5.9; 
95% CI, 1.6-21.8; P = .01) and discussion of HIV testing 
during prenatal care (OR, 4.5; 95% CI, 1.8-11.0; P = .001).
Discussion
Prenatal HIV testing was substantially more common 
in Cameron County than in Matamoros, according to both 
bivariate and regression analyses. Both also showed that 
women in Matamoros with a low level of formal education 
or who were not knowledgeable about adult-to-adult HIV 
infection prevention were less likely to be tested. Variables 
associated  with  prenatal  HIV  testing  did  not  have  the 
same influence in each community. To confirm these find-
ings, we ran a regression for the total sample that included 
interaction terms for place of residence with variables that 
were significant in any of the models, and this regression 
confirmed the explanatory power of place of residence.
Univariate  distributions  showed  that  in  some  ways 
these  2  border  communities  were  similar,  but  in  oth-
ers they varied widely. For example, the distribution of 
women aged 20 to 34 years was similar in Matamoros and 
Cameron County, as was the proportion of those employed 
and the proportion of those who were insured during their 
pregnancy. However, women varied in their level of edu-
cation, which may result partly from differences in the 
educational systems in the United States and Mexico and 
from differences in socioeconomic status in each commu-
nity. Women also varied in terms of smoking and drinking 
alcohol (especially drinking). Alcohol abuse and cigarette 
smoking  are  common  among  people  with  HIV  infection 
(19), although these behaviors were not significantly asso-
ciated with prenatal HIV testing in either community.
In  addition  to  individual-level  characteristics,  public 
health research must consider policy and practice. In this 
project, the role of place was probably influenced by nation-
al policy regarding prenatal HIV testing. The most recent 
US policy recommendations state that HIV testing should 
be offered to all pregnant women as part of standard pre-
natal tests, regardless of risk factors and prevalence rates 
in the community (20). The results from this survey sug-
gest the US policy is successful, since nearly 95% of women 
who resided in Cameron County (and presumably received 
their prenatal care in their place of residence) were given 
an HIV test during their most recent pregnancy.
Mexican  policy  also  recommends  HIV  testing  during 
prenatal care (12); however, the practice of testing varies 
among insurers. The Mexican health care system is differ-
ent from the US system in that major insurers also provide 
services (21), and not all insurers pay for HIV testing. The 
Mexican  Social  Security  Institute  insures  employees  in 
the private sector and covers the cost of HIV testing (21). 
The Social Security Institute for Government Employees, 
which insures federal employees, also covers the cost of an 
HIV test. However, the Ministry of Health in Tamaulipas, 
which serves the uninsured poor, does not cover the cost of 
an HIV test. An exception is made for high-risk patients, 
such as injection drug users or people with tattoos (21), but 
otherwise, women in Tamaulipas covered by the Ministry 
of Health must pay for their own HIV test.
This policy varies by state in Mexico. Other states, such 
as  Nuevo  León,  have  resources  available  through  the 
Ministry of Health to pay for widespread HIV testing. In 
2007, Mexico initiated a new strategy to use rapid HIV 
testing for all pregnant women as part of routine prenatal 
care, with signed consent. Previous policy mandated HIV 
testing only among women who tested positive for syphilis. 
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However, gauging how this new strategy will affect prac-
tice in Mexico will take time.
Our finding of low rates of HIV testing in Matamoros 
is  consistent  with  other  research.  One  study  reported 
that  HIV  testing  during  pregnancy  at  Tijuana  General 
Hospital is not routinely done (22). Another study reported 
low rates of testing among high-risk groups in Tijuana 
and Ciudad Juarez (38% and 30%, respectively) (23). This 
study also reported a significant association between low 
education and not having been tested for HIV (23). Our 
findings are also consistent with previous findings that 
knowledge of methods to prevent perinatal HIV transmis-
sion was associated with HIV testing (23,24).
Findings regarding prenatal HIV testing are mixed in 
the literature. Previous testing may be a proxy for risk. 
One recent study suggests that previous HIV testing (ie, 
knowing  one’s  status)  may  promote  risky  behaviors.  A 
study of sex workers in West Africa found that prior HIV 
testing was associated with decreased condom use (25). 
In contrast, a study of men who have sex with men found 
no association between risk (sex and drug use) behaviors 
and testing during the preceding year (26). In the BMSCP 
data, previous HIV testing was not significantly correlated 
with condom use (among those women not trying to get 
pregnant) or with the measure of HIV risk (intravenous 
drug use, treatment for sexually transmitted infection, or 
multiple sex partners) in the total sample or in Cameron 
County.  However,  previous  HIV  testing  was  correlated 
with condom use in Matamoros (P = .05), where a greater 
proportion of women who were previously tested for HIV 
did not use condoms at the time of conception (results not 
shown).
Limitations
These  data  were  collected  in  only  1  border  area  of  2 
sister  cities.  Although  these  findings  may  likely  reflect 
the situation in other border areas and sister cities, they 
are not necessarily representative of other border areas 
and sister cities. In addition, the question that measured 
HIV risk asked only about “intravenous” drug use in the 
past  year.  A  more  precise  measure  of  risk  would  have 
asked about “injection” drug use, since some drug users 
inject intramuscularly or subcutaneously. Also, to main-
tain validity of data collection, questions asked in both 
communities were identical, which led to some ambiguity 
for Matamoros respondents because questions regarding 
health insurance and Hispanic ethnicity were not entirely 
applicable. Finally, the BMSCP data do not contain infor-
mation  on  where  respondents  received  prenatal  care, 
which would be salient to this research because prenatal 
care is the most likely setting for an HIV test during preg-
nancy. US-Mexico border residents often seek health care 
on the “other side” of the border (27,28). The data contain, 
however, information on where respondents sought gen-
eral medical care, and women who reported seeking care 
either  in  the  nonresident  country  or  in  both  countries 
were considered to have crossed the border for care. Seven 
percent (95% CI, 5.0%-9.7%) of Cameron County residents 
and  3.6%  (95%  CI,  2.6%-4.9%)  of  Matamoros  residents 
reported that they crossed the border for medical care. If 
many women receive prenatal care across the border, then 
place of residence may not be the most appropriate mea-
sure to use when assessing policy implications.
Conclusions
Variables that explain prenatal HIV testing are differ-
ent on each side of the Texas-Tamaulipas border. Only 
2  variables  were  significant  in  both  Matamoros  and 
Cameron County, previous HIV testing and discussion of 
HIV testing during prenatal care, but the magnitude of the 
odds and statistical significance varied across the border. 
Still, this finding shows that HIV testing should be dis-
cussed during prenatal care to engage pregnant women in 
preventive care. The demographic and practice differences 
between Matamoros and Cameron County are a challenge 
to health officials because they may preclude sharing inter-
vention strategies across the border. However, practitio-
ners may be able to use the knowledge of these differences 
to increase testing rates in pregnant patients. HIV testing 
during pregnancy is essential to minimize mother-to-child 
transmission and to identify previously undiagnosed cases 
so that patients may begin chronic care.
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Table 1. Demographic Characteristics of Women Who Gave Birth in the Texas-Tamaulipas Border Region, 2005: the 
Brownsville-Matamoros Sister City Project for Women’s Health
Characteristic
Country of Residencea
Total Sample (N = 947) Mexico (n = 489) United States (n = 458)
n
Weighted % (95% 
CI) n
Weighted % (95% 
CI) n
Weighted % (95% 
CI)
Country of deliveryb
United States 2 5.1 (.9-6.5) 45 99.8 (98.6-100.0) 484 48.4 (45.5-51.4)
Mexico 462 95.0 (9.6-96.1) 1 0.2 (0.0-1.4) 46 51.6 (48.6-54.5
Age, y
14-19 94 19.2 (16.5-22.) 68 14.8 (11.9-18.) 162 1.2 (15.2-19.4)
20-24 154 1.5 (2.8-5.6) 141 0.8 (2.5-4.4) 295 1.2 (28.6-4.0)
25-4 20 42. (8.8-46.0) 202 44.0 (40.5-4.) 409 4.1 (40.6-45.6)
5-9 26 5. (.6-.6) 9 8.6 (6.2-11.) 65 6.8 (5.-8.6)
40-4 8 1.6 (0.9-2.8) 8 1. (0.9-.) 16 1. (1.1-2.5)
Ethnicityb,c,d
Hispanic 489 100.0 94 88.9 (85.5-91.6) 88 95.0 (9.4-96.2)
Non-Hispanic 0 0 49 11.1 (8.4-14.5) 49 5.0 (.8-6.6)
Country of birthd
Mexico 48 99.2 (98.1-99.6) 195 4.2 (8.2-48.) 68 . (0.5-6.6)
United States 2 0.4 (0.1-1.) 251 55.5 (50.0-60.9) 25 25.5 (22.5-28.9)
Other 2 0.4 (0.1-1.) 6 1. (0.-2.) 8 0.8 (0.5-1.5)
Marital statusb,d,e
Single 46 9.4 (.-12.0) 119 26. (22.-0.2) 165 1.1 (15.0-19.4)
Live-in significant other 181 . (.8-41.0) 111 24.6 (21.-2.6) 292 1.5 (29.1-4.0)
Married 259 5. (49.2-5.) 222 49.1 (45.-5.0) 481 51.4 (48.6-54.2)
Education, yb,d
≤7 154 1. (28.4-5.) 5 11.8 (9.2-14.9) 20 22.6 (20.4-25.0)
8-12 (no high school diploma) 248 51.1 (4.2-55.0) 168 .4 (2.9-42.0) 416 44.9 (41.8-48.0)
>12 (at least high school diploma) 84 1.1 (1.9-20.9) 229 50.9 (46.1-55.) 1 2.5 (29.-5.9)
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Abbreviation: CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the place where they delivered. 
b Included in multivariate regression models. Yielded a P value ≤.10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
c All women who reported living in Mexico were coded as Hispanic. 
d Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
e Women who reported being single, widowed, divorced, or separated were coded as single. 
f Homemaker, student, retired, or unable to work. 




Total Sample (N = 947) Mexico (n = 489) United States (n = 458)
n
Weighted % (95% 
CI) n
Weighted % (95% 
CI) n
Weighted % (95% 
CI)
Employment statusb,d
Employed 28 49.0 (45.-52.6) 216 4.9 (42.8-5.1) 454 48.5 (45.4-51.6)
Unemployed 24 4.8 (.4-6.8) 48 10. (.6-15.0) 2 .5 (5.8-9.8)
Not in labor forcef 226 46.2 (42.6-49.) 186 41. (5.8-4.1) 412 44.0 (40.8-4.)
Health care coverageb,d
Before pregnancy
  Coverage 28 58.1 (54.4-61.8) 116 25. (21.4-29.5) 99 4.1 (40.2-46.0)
  No coverage 206 41.9 (8.2-45.6) 41 4.8 (0.5-8.6) 54 56.9 (54.0-59.8)
During pregnancy
  Coverage  69.4 (66.6-2.1) 16 69.2 (65.9-2.4) 65 69.4 (6.2-1.4)
  No coverage 151 0.6 (2.9-.4) 140 0.8 (2.6-4.2) 291 0. (28.6-2.8)
 
Abbreviation: CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the place where they delivered. 
b Included in multivariate regression models. Yielded a P value ≤.10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
c All women who reported living in Mexico were coded as Hispanic. 
d Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
e Women who reported being single, widowed, divorced, or separated were coded as single. 
f Homemaker, student, retired, or unable to work. 
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Table 1. (continued) Demographic Characteristics of Women Who Gave Birth in the Texas-Tamaulipas Border Region, 2005: 
the Brownsville-Matamoros Sister City Project for Women’s HealthTable 2. Distribution of HIV Testing, Knowledge, and Risk Variables Among Women Who Gave Birth in the Texas-Tamaulipas 
Border Region, 2005: the Brownsville-Matamoros Sister City Project for Women’s Health 
Variable
Country of Residencea
Total Sample (N = 947) Mexico (n = 489) United States (n = 458)
n
Weighted % (95% 
CI) n
Weighted % (95% 
CI) n
Weighted % (95% 
CI)
HIV testingb
Had an HIV test during pregnancy
  Yes 260 5.6 (5.5-61.) 402 94.8 (92.-96.4) 662 4. (1.8-.5)
  No 189 42.4 (8.-46.5) 22 5.2 (.6-.) 211 25. (22.6-28.2)
Timing of most recent HIV test
  1st trimester 8 4. (2.8-41.4) 0 1.6 (14.5-21.2) 15 24.5 (21.2-28.2)
  2nd trimester 81 1.9 (2.0-.) 40 10.2 (.4-1.8) 121 19.2 (16.4-22.)
  rd trimester  0.1 (25.1-5.) 59 14.9 (11.2-19.5) 16 21.2 (18.1-24.)
  During pregnancy, but did not know when 5 1.8 (0.9-.9) 90 22. (18.8-2.1) 95 14.0 (11.5-1.1)
  During labor/delivery 5 1.8 (0.8-4.4) 16 4.2 (28.0-41.1) 141 20.8 (1.1-25.1)
  After delivery 0 0 2 0.5 (0.1-1.8) 2 0. (0.1-1.0)
Offered HIV test during pregnancy
  Yes 20 4. (40.0-4.4) 94 91.0 (8.8-9.5) 59 65.4 (62.4-68.2)
  No 259 56. (52.6-60.0) 9 9.0 (6.5-12.2) 298 4.6 (1.8-.6)
Refused HIV test during pregnancyc
  Yes 5 2.5 (1.1-5.6) 4 1.0 (0.5-2.) 9 1.6 (0.9-2.8)
  No 198 9.5 (94.4-98.9) 8 99.0 (9.-99.5) 585 98.4 (9.2-99.1)
Tested for HIV before pregnancyd
  Yes 110 2.5 (19.6-2.9) 2 54.5 (50.-58.) 4 . (4.-40.8)
  No 55 6.5 (2.1-80.4) 198 45.5 (41.-49.8) 55 62. (59.-65.)
How long before pregnancy was HIV testd
  <6 mo 45 41.5 (.8-49.)  15.8 (11.6-21.) 82 24.5 (20.-29.)
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Abbreviations: HIV, human immunodeficiency virus; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the country where they delivered. 
b Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
c Reasons for refusing an HIV test included not having money (n = 4), confidence in HIV-negative status (n = 4), and belief the test would hurt the baby (n 
= 1). 
d Included in multivariate regression models. Yielded a P value ≤.10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
e The original item was open-ended. Only those methods described in the Compendium of Indicators for Evaluating Reproductive Health Programs are  
reported here. 
f Respondents who smoked any cigarettes on an average day were classified as smokers. 
g Respondents who drank any alcohol were classified as alcohol users. 
h Respondents who consumed ≥5 alcoholic drinks in 1 sitting at least once were classified as binge drinkers. 




Total Sample (N = 947) Mexico (n = 489) United States (n = 458)
n
Weighted % (95% 
CI) n
Weighted % (95% 
CI) n
Weighted % (95% 
CI)
How long before pregnancy was HIV testd (continued)
  6-12 mo 10 9.0 (4.-16.6) 50 21.2 (16.4-2.0) 60 1.1 (1.-21.8)
  >1 y 54 49.5 (42.-56.) 148 6.0 (56.5-69.0) 202 58.4 (5.4-6.)
Prenatal care and HIV informationb
Timing of prenatal cared
  1st trimester 21 45.0 (41.4-48.) 29 62.0 (58.5-65.4) 496 52.8 (50.-55.)
  2nd trimester 228 4.5 (44.2-50.9) 152 .8 (0.1-.) 80 41.2 (8.-4.8)
  rd trimester 19 4.0 (2.6-6.0) 16 .5 (2.5-5.0) 5 .8 (2.8-5.0)
  Did not receive 1 .5 (2.-5.2)  0. (0.-1.8) 20 2.2 (1.5-.2)
Prenatal care early as wantedd
  Yes 445 91.4 (88.-9.5) 418 91.5 (89.8-9.0) 86 91.5 (89.9-92.8)
  No 6 .4 (5.5-10.0) 8 8. (6.9-10.0) 4 .8 (6.5-9.)
  Did not want 6 1.2 (0.6-2.6) 1 0.2 (0.0-1.2)  0.8 (0.4-1.5)
Discussed getting tested for HIV during prenatal care visitsd
  Yes 264 55.8 (51.6-60.0) 6 4.4 (6.8-80.1) 600 64.4 (60.6-68.1)
  No 208 44.2 (40.0-48.4) 116 25.6 (19.9-2.) 24 5.6 (2.0-9.4)
Discussed HIV/sexually transmitted disease prevention during prenatal care visitsd
  Yes 228 48.5 (44.-52.) 26 58.2 (52.1-64.0) 491 5.0 (49.5-56.4)
  No 24 51.5 (4.4-55.) 190 41.8 (6.0-4.9) 4 4.0 (4.6-50.5)
Knowledge of HIV infection preventiond,e
Mentioned condom use 02 61. (56.-66.5) 29 64.9 (58.5-0.) 599 6.2 (59.2-66.9)
Mentioned monogamy 15 .1 (1.-5.) 18 .9 (2.5-6.2)  .5 (2.4-4.9)
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Abbreviations: HIV, human immunodeficiency virus; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the country where they delivered. 
b Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
c Reasons for refusing an HIV test included not having money (n = 4), confidence in HIV-negative status (n = 4), and belief the test would hurt the baby (n 
= 1). 
d Included in multivariate regression models. Yielded a P value ≤.10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
e The original item was open-ended. Only those methods described in the Compendium of Indicators for Evaluating Reproductive Health Programs are  
reported here. 
f Respondents who smoked any cigarettes on an average day were classified as smokers. 
g Respondents who drank any alcohol were classified as alcohol users. 
h Respondents who consumed ≥5 alcoholic drinks in 1 sitting at least once were classified as binge drinkers. 
(Continued on next page)
Table 2. (continued) Distribution of HIV Testing, Knowledge, and Risk Variables Among Women Who Gave Birth in the Texas-
Tamaulipas Border Region, 2005: the Brownsville-Matamoros Sister City Project for Women’s Health Variable
Country of Residencea
Total Sample (N = 947) Mexico (n = 489) United States (n = 458)
n
Weighted % (95% 
CI) n
Weighted % (95% 
CI) n
Weighted % (95% 
CI)
Knowledge of HIV infection preventiond,e (continued) 
Mentioned both 112 2.0 (20.0-26.1) 50 10.9 (8.6-1.8) 162 1.4 (15.4-19.)
Did not mention either 60 12. (8.8-16.8) 9 20. (15.8-25.6) 15 15.9 (1.1-19.)
Risk factors for HIV infection in past yeard
≥1 28 5.8 (4.4-.5) 26 5.8 (4.5-.5) 54 5.8 (4.8-6.9)
None 460 94.2 (92.5-95.6) 426 92.6 (92.6-95.5) 886 94.2 (9.1-95.2)
Risk behaviors 3 mo before pregnancy
Smoked cigarettesd,f
  Yes 24 4.9 (.-6.5) 6 .9 (6.2-10.1) 60 6. (5.2-.6)
  No 464 95.1 (9.5-96.) 419 92.1 (89.9-9.9) 88 9. (92.4-94.8)
Drank alcohold,g
  Yes 66 1.5 (11.1-16.) 15 4.5 (1.0-8.) 22 2.1 (21.1-25.)
  No 422 86.5 (8.-88.9) 298 65.5 (61.-69.1) 20 6.9 (4.8-9.0)
Binge drinkingd,h
  Yes 0 6.2 (4.8-.9) 59 1.0 (10.2-16.5) 89 9. (.8-11.0)
  No 458 9.9 (92.1-95.2) 94 8.0 (8.6-89.8) 852 90. (89.1-92.2)
 
Abbreviations: HIV, human immunodeficiency virus; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the country where they delivered. 
b Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
c Reasons for refusing an HIV test included not having money (n = 4), confidence in HIV-negative status (n = 4), and belief the test would hurt the baby (n 
= 1). 
d Included in multivariate regression models. Yielded a P value ≤.10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
e The original item was open-ended. Only those methods described in the Compendium of Indicators for Evaluating Reproductive Health Programs are report-
ed here. 
f Respondents who smoked any cigarettes on an average day were classified as smokers. 
g Respondents who drank any alcohol were classified as alcohol users. 
h Respondents who consumed ≥5 alcoholic drinks in 1 sitting at least once were classified as binge drinkers. 
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Table 2. (continued) Distribution of HIV Testing, Knowledge, and Risk Variables Among Women Who Gave Birth in the Texas-
Tamaulipas Border Region, 2005: the Brownsville-Matamoros Sister City Project for Women’s Health VOLUME 5: NO. 4
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Table 3. Percentage of Women Who Had an HIV Test Among Women Who Gave Birth in the Texas-Tamaulipas Border Region, 
by Demographic Characteristics, 2005: the Brownsville-Matamoros Sister City Project for Women’s Health 
Characteristic
Country of Residencea
Total Sample (N = 662) Mexico (n = 260) United States (n = 402)
n
Weighted % (95% 
CI) n
Weighted % (95% 
CI) n
Weighted % (95% 
CI)
Country of deliveryb
United States 25 100.0 402 95.1 (9.0-96.6) 42 95.4 (9.4-96.)
Mexico 25 55.4 (51.1-59.6) 0 0 25 55.2 (51.0-59.4)
Age, y
14-19 44 48.6 (41.5-55.8) 55 90. (82.6-94.8) 99 64.4 (59.1-69.4)
20-24 5 52.9 (44.6-61.1) 122 9.1 (88.2-96.1) 19 1. (65.1-6.)
25-4 11 62. (56.2-68.6) 184 96. (9.-98.0) 01 8.8 (5.0-82.2)
5-9 21 8.8 (6.2-9.9) 4 100.0 55 92.8 (81.2-9.4)
40-4  42.2 (14.9-5.4)  100.0 10 69. (45.2-86.5)
Ethnicityb,c,d
Hispanic 260 5.6 (5.5-61.) 49 94.9 (92.6-96.5) 609 .5 (0.4-6.)
Non-Hispanic 0 0 42 9.1 (.9-98.1) 42 9.1 (.9-98.1)
Country of birthd
Mexico 258 5.8 (5.-61.9) 1 95.6 (92.-9.5) 41 68.0 (64.5-1.)
United States 2 100.0 221 94.5 (91.6-96.4) 22 94.5 (91.-96.5)
Other 0 0 5 8.1 (41.1-9.2) 5 60.5 (0.-84.4)
Marital statusb,d,e
Single 26 58.4 (48.2-68.0) 105 95.5 (91.0-9.8) 11 84.2 (8.9-88.4)
Live-in significant other 9 46.5 (40.2-52.8) 94 9.1 (8.4-96.4) 1 62.8 (5.-68.0)
Married 155 66.0 (60.4-1.2) 200 95.2 (92.4-9.0) 55 9.1 (5.8-82.1)
Education, yb,d
≤7 2 49.8 (41.9-5.6) 44 95. (85.5-98.8) 116 60.0 (5.2-66.4)
8-12 (no high school diploma) 126 56.6 (49.-6.5) 141 92.8 (89.0-95.) 26 0.4 (65.2-5.1)
>12 (at least high school diploma) 61 4.9 (66.9-81.6) 212 96.0 (9.0-9.) 2 89.9 (86.6-92.5)
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Abbreviations: HIV, human immunodeficiency virus; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the place where they delivered. 
b Included in multivariate regression models. Yielded a P value ≤10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
c All women who reported living in Mexico were coded as Hispanic. 
d Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
e Women who reported being single, widowed, divorced, or separated were coded as single. 
f Homemaker, student, retired, or unable to work. 
(Continued on next page)Characteristic
Country of Residencea
Total Sample (N = 662) Mexico (n = 260) United States (n = 402)
n
Weighted % (95% 
CI) n
Weighted % (95% 
CI) n
Weighted % (95% 
CI)
Employment statusb,d
Employed 12 61.2 (55.0-6.0) 19 96.0 (92.5-98.0) 25 .1 (2.5-81.1)
Unemployed 12 56. (6.2-4.5) 44 91.6 (8.-96.0) 56 80. (0.0-8.6)
Not in labor forcef 116 54.1 (48.6-59.5) 160 94.1 (90.5-96.4) 26 0.9 (6.0-4.5)
Health care coverageb,d
Before pregnancy
  Coverage 15 59.0 (52.9-64.8) 104 9. (9.-98.9) 25 69. (64.2-.9)
  No coverage 10 55.8 (49.-62.0) 298 94.0 (91.0-96.0) 405 8.8 (5.2-82.1)
During pregnancyd
  Coverage 185 59.8 (55.-64.1) 29 95.9 (9.-9.6) 464 6. (.0-9.4)
  No coverage 5 52.8 (44.-60.) 122 92.4 (8.2-95.6) 19 1.1 (65.8-5.9)
 
Abbreviations: HIV, human immunodeficiency virus; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the place where they delivered. 
b Included in multivariate regression models. Yielded a P value ≤10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
c All women who reported living in Mexico were coded as Hispanic. 
d Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
e Women who reported being single, widowed, divorced, or separated were coded as single. 
f Homemaker, student, retired, or unable to work. 
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Table 3. (continued) Percentage of Women Who Had an HIV Test Among Women Who Gave Birth in the Texas-Tamaulipas 
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Table 4. Percentage of Women Who Had an HIV Test Among Women Who Gave Birth in The Texas-Tamaulipas Border 




Total Sample (N = 662) Mexico (n = 260) United States (n = 402)
n Weighted % (95% CI) n Weighted % (95% CI) n Weighted % (95% CI)
HIV testingb
Offered HIV test during pregnancy
  Yes 186 92.0 (8.9-94.8)  98. (9.2-99.4) 56 96.2 (94.4-9.4)
  No 68 28.4 (24.-2.8) 19 54.2 (40.6-6.) 8 1. (2.1-5.9)
Refused HIV test during pregnancyc
  Yes 0 0  5.2 (26.5-96.2)  1.6 (11.5-62.1)
  No 186 94. (90.9-96.5) 4 98.9 (9.5-99.6) 560 9. (95.8-98.2)
Tested for HIV before pregnancyd
  Yes 88 82.8 (5.8-88.1) 225 98.2 (95.1-99.4) 1 9.0 (89.8-95.)
  No 164 48. (44.0-5.4) 168 90.4 (85.4-9.8) 2 62.6 (58.-66.)
How long before pregnancy was HIV testd
  <6 mo 6 85.6 (6.8-91.4) 5 9.1 (84.9-99.5) 1 90.6 (84.5-94.5)
  6-12 mo 9 89. (61.2-98.0) 48 100.0 5 98.1 (89.8-99.)
  >1 y 42 9.0 (66.8-8.6) 140 9.9 (92.2-99.4) 182 92.4 (8.5-95.5)
Prenatal care and HIV informationb,d
Timing of prenatal care
  1st trimester 129 65.6 (5.5-2.9) 24 95.0 (91.9-96.9) 6 81.6 (.2-85.)
  2nd trimester 114 5.8 (48.2-59.) 16 95.1 (90.6-9.5) 250 69.5 (65.4-.2)
  rd trimester 12 66.4 (4.1-81.4) 1 100.0 25 9.6 (66.1-88.)
  Did not receive  1.9 (.0-8.) 1 51.1 (8.0-92.6) 4 21. (9.8-40.4)
Prenatal care early as wanted
  Yes 24 59. (54.-6.) 68 95.1 (92.8-96.) 611 5.8 (2.-8.6)
  No 14 40.8 (24.-59.) 4 94.5 (82.5-98.4) 48 6.0 (54.6-.4)
  Did not want 2 9.1 (8.8-81.1) 0 0 2 .1 (8.0-.9)
Abbreviations: HIV, human immunodeficiency virus; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the place where they delivered. 
b Included in multivariate regression models. Yielded a P value ≤10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
c All women who reported living in Mexico were coded as Hispanic. 
d Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
e Women who reported being single, widowed, divorced, or separated were coded as single. 
f Homemaker, student, retired, or unable to work. 
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Variable
Country of Residencea
Total Sample (N = 662) Mexico (n = 260) United States (n = 402)
n Weighted % (95% CI) n Weighted % (95% CI) n Weighted % (95% CI)
Discussed getting tested for HIV during prenatal care visits
  Yes 191 .1 (.5-80.4) 1 9.5 (95.1-98.) 504 88.1 (85.9-90.0)
  No 66 5. (29.4-41.) 8 8.0 (.9-92.) 15 52.1 (45.-58.4)
Discussed HIV/sexually transmitted disease prevention during prenatal care visits
  Yes 150 0.2 (66.1-4.1) 240 95. (92.4-9.1) 90 8.2 (80.4-85.6)
  No 106 48.0 (41.9-54.) 160 94.6 (90.8-96.9) 266 6.1 (62.-1.)
Knowledge of HIV infection preventiond,e
Mentioned condom use 161 56. (51.8-60.4) 21 94.4 (91.8-96.2) 42 4. (1.8-.5)
Mentioned monogamy 10 66. (6.5-8.1) 15 94.0 (0.-99.0) 25 4.4 (0.9-.6)
Mentioned both 5 0.1 (59.-8.) 44 95. (85.9-98.8) 119 9.9 (60.6-91.1)
Did not mention either 14 2. (21.8-45.9) 2 96.0 (86.1-99.0) 86 .2 (69.5-8.5)
Risk factors for HIV infection in past yeard
≥1 18 64.1 (46.-8.5) 25 100.0 4 80.1 (6.8-88.6)
None 242 5.2 (5.-61.0) 5 94.5 (92.2-96.1) 61 4. (1.6-6.9)
Risk behaviors 3 mo before pregnancy
Smoked cigarettesd,f
  Yes 1 . (5.8-8.0) 2 94.1 (81.0-98.) 49 85. (.9-92.)
  No 24 56.8 (52.5-60.9) 69 94.9 (92.-96.4) 612 4.0 (1.0-6.)
Drank alcohold,g
  Yes 40 65. (54.8-4.4) 141 9.9 (88.8-96.8) 181 85.1 (9.8-89.2)
  No 220 56.4 (51.5-61.) 260 95. (92.-9.2) 480 1.5 (6.9-4.9)
Binge drinkingd,h
  Yes 20 68. (52.-81.5) 52 91.2 (82.4-95.8) 2 8.1 (4.8-89.1)
  No 240 56.9 (52.2-61.4) 4 95. (9.1-96.9) 58 .8 (0.5-6.8)
 
Abbreviations: HIV, human immunodeficiency virus; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the country where they delivered. 
b Frequencies do not add to n’s because of missing data. “Don’t know” or “refused” responses were included as missing data. 
c Women stated confidence in HIV-negative status as the reason for refusing an HIV test (n = ). 
d Included in multivariate regression models. Yielded a P value ≤.10 in bivariate regression with HIV screening during pregnancy in Matamoros, Cameron 
County, or total sample. 
e The original item was open-ended. Only those methods described in the Compendium of Indicators for Evaluating Reproductive Health Programs are  
reported here. 
f Respondents who smoked any cigarettes on an average day were classified as smokers. 
g Respondents who drank any alcohol were classified as alcohol users. 
h Respondents who consumed ≥5 alcoholic drinks in 1 sitting at least once were classified as binge drinkers. 
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Table 5. Factors Associated in Logistic Regression With Having Had an HIV Test During Pregnancy, 2005: the Brownsville-
Matamoros Sister City Project for Women’s Health 
Variable OR (95% CI) P value
Place of residencea
Matamoros 1.00  
Cameron County 11.65 (6.65-20.42) <.001
Age, y
14-19 1.00  
20-24 0.5 (0.44-1.2) .28
25-4 1.5 (0.86-2.12) .19
5-4 2.4 (1.44-5.22) .00
Tested for HIV before pregnancy
Yes 4.6 (.2-.00) <.001
No 1.00  
Discussed HIV testing with health care professional during prenatal care
Yes 5.52 (.89-.82) <.001
No 1.00  
Knowledge of HIV infection prevention methodsb
Mentioned either condom use or monogamy with an uninfected partner 1.82 (1.00-.1) .05
Mentioned both methods 2.8 (1.46-5.4) .002
Did not mention either method 1.00  
 
Abbreviations: HIV, human immunodeficiency virus; OR, odds ratio; CI, confidence interval. 
a Women who reported living in both the United States and Mexico or did not respond to this item were coded as living in the country where they delivered. 
b The original item was open-ended. Only those methods described in the Compendium of Indicators for Evaluating Reproductive Health Programs are  
reported here. VOLUME 5: NO. 4
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Table 6. Factors Associated in Logistic Regression With Having Had an HIV Test During Pregnancy Among Women in 
Matamoros, 2005: the Brownsville-Matamoros Sister City Project for Women’s Health 
Variable OR (95% CI) P value
Marital statusa
Single 0.99 (0.54-1.82) .98
Live-in significant other 0.5 (0.8-0.84) .01
Married 1.00  
Education, y
≤7 1.00  
8-12 (no high school diploma) 1.28 (0.8-2.10) .2
>12 (at least high school diploma) 2.19 (1.19-4.0) .02
Tested for HIV before pregnancy
Yes .56 (2.29-5.55) <.001
No 1.00  
Discussed HIV testing with health care professional during prenatal care
Yes 6.52 (4.1-9.99) <.001
No 1.00  
Knowledge of HIV infection prevention methodsb
Mentioned either condom use or monogamy with an uninfected partner .06 (1.48-6.1) .00
Mentioned both methods 4.0 (2.08-8.90) <.001
Did not mention either method 1.00  
 
Abbreviations: HIV, human immunodeficiency virus; OR, odds ratio; CI, confidence interval. 
a Women who reported being single, widowed, divorced, or separated were coded as single. 
b The original item was open-ended. Only those methods described in the Compendium of Indicators for Evaluating Reproductive Health Programs are  
reported here.